METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis
Journal of Bioenergetics and Biomembranes · 2026-12 · 58 (1)
DOI: 10.1007/s10863-026-10100-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bioenergetics and Biomembranes, online erschienen am 18.03.2026. Verfasst von Mao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Thyroid and Breast Surgery, Zhuji People's Hospital, Zhuji, 311800, Zhejiang, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Breast Neoplasms, Glycolysis. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thyroid and Breast Surgery, Zhuji People's Hospital, Zhuji, 311800, Zhejiang, China.
- Breast Surgery, Zhuji Maternity and Child Health Hospital, No.1 Yuxin Road, Jiyang Street, Zhuji, 311800, Zhejiang, China. zjyihaocai@163.com.
Zitieren
APA
Li, M., Shen, H., Zhang, T., Jin, X., Jin, G., & Cai, Y. (2026). METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis. Journal of Bioenergetics and Biomembranes, 58(1). https://doi.org/10.1007/s10863-026-10100-6
Vancouver
Li M, Shen H, Zhang T, Jin X, Jin G, Cai Y. METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis. Journal of Bioenergetics and Biomembranes. 2026;58(1). doi:10.1007/s10863-026-10100-6
BibTeX
@article{Li2026,
author = {Li, Mao and Shen, Haipeng and Zhang, Tianya and Jin, Xin and Jin, Gaopei and Cai, Yihao},
title = {METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis},
journal = {Journal of Bioenergetics and Biomembranes},
year = {2026},
volume = {58},
number = {1},
doi = {10.1007/s10863-026-10100-6}
}
EUVIMED